Anthony Hickey

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Search Results

Phase i, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis

Development of An Hplc Method to Determine Cpzen-45 in Biological Matrices

Pharmacokinetics of Cpzen-45, A Novel Anti-Tuberculosis Drug in Male Guinea Pigs

Development of A Human Lung Co-Culture Model System for Hazard Identification of Aerosolized Particles

New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation

Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder

Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis

Effects of direct spiking of silicone oil into a model pMDI formulation

Dry powder antibiotic aerosol development: Inhaled therapy for tuberculosis

Back to the future: Inhaled drug products

Ergonomic and High Efficiency Trans-Nasal Aerosol Delivery Platform Targeting Pulmonary Deposition with Minimal Deposition in the Nose

Evaluation of Intranasal Delivery of A Viable Bacterial Aerosol for Bovine Immunization

Aerosol Delivery Through High Flow Nasal Cannulae

Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples

Hickey honored by American Association of Indian Pharmaceutical Scientists